Occipital Fibrosing Alopecia in a Young Male: A Case Report
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
KARGER
Citação
SKIN APPENDAGE DISORDERS, v.7, n.1, p.71-74, 2021
Resumo
Introduction: Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia with 3 recognized clinical variants. Lately, LPP clinical spectrum has expanded with new and overlapping clinical variants. First considered as a subtype of LPP affecting postmenopausal women, the increasing worldwide incidence of FFA including atypical lesions in young female and male suggests a different pathomechanism for this disease. Although LPP-spectrum disorders may share similar histopathological findings, clinical features and prognosis are different. Case Report: A 26-year-old Caucasian male presented with occipital scarring alopecia and pruritus for the last 6 months. The patient had been treated for an associated androgenetic alopecia and superficial recurrent scalp folliculitis over the vertex scalp for the last 5 years. Trichoscopy of the occipital scalp showed mild diffuse erythema, moderate peripilar scaling, and absence of follicular openings, suggestive of a scarring process. The patient underwent an occipital scalp biopsy that confirmed the diagnosis of a LPP-spectrum disorder. Discussion/Conclusion: Both LPP and FFA mostly affect the anterior-mid scalp of females. However, recent reports on FFA also in premenopausal women and men should make physicians aware of atypical features of this disease and unusual clinical presentation.
Palavras-chave
Frontal fibrosing alopecia, Lichen planopilaris, Scarring alopecia, Primary scarring alopecia, Occipital alopecia, Occipital fibrosing alopecia
Referências
- Abbas O, 2007, J AM ACAD DERMATOL, V57, pS15, DOI 10.1016/j.jaad.2006.11.010
- Babahosseini H, 2019, J DERMATOL TREAT, V30, P598, DOI 10.1080/09546634.2018.1542480
- Cervantes J, 2018, SKIN APPENDAGE DISOR, V4, P50, DOI 10.1159/000479116
- Doche I, 2020, J EUR ACAD DERMATOL, V34, pE326, DOI 10.1111/jdv.16287
- Doche I, 2020, EXP DERMATOL, V29, P278, DOI 10.1111/exd.13834
- Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369
- Katoulis AC, 2018, J EUR ACAD DERMATOL, V32, pE218, DOI 10.1111/jdv.14748
- KOSSARD S, 1994, ARCH DERMATOL, V130, P770, DOI 10.1001/archderm.130.6.770
- Meinhard J, 2014, J DTSCH DERMATOL GES, V12, P229, DOI 10.1111/ddg.12264
- Melo DF, 2020, J EUR ACAD DERMATOL, V34, pE405, DOI 10.1111/jdv.16337
- Mirmirani P, 2005, J AM ACAD DERMATOL, V52, P637, DOI 10.1016/j.jaad.2004.07.069
- Ormaechea-Perez N, 2016, ACTAS DERMO-SIFILOGR, V107, P836, DOI 10.1016/j.ad.2016.07.004
- Rakowska A, 2012, J DRUGS DERMATOL, V11, P753
- Ramanauskaite Ausrine, 2015, Int J Trichology, V7, P119, DOI 10.4103/0974-7753.167463
- Tolkachjov SN, 2017, J AM ACAD DERMATOL, V77, P683, DOI 10.1016/j.jaad.2017.05.045
- Weston Gillian, 2015, Int J Womens Dermatol, V1, P140, DOI 10.1016/j.ijwd.2015.04.001